{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T12:27:23Z","timestamp":1791203243829,"version":"4.2.0"},"reference-count":74,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,16]],"date-time":"2020-09-16T00:00:00Z","timestamp":1600214400000},"content-version":"vor","delay-in-days":2177,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Lipid Research"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1194\/jlr.m049262","type":"journal-article","created":{"date-parts":[[2014,6,30]],"date-time":"2014-06-30T00:26:38Z","timestamp":1404087998000},"page":"2053-2063","source":"Crossref","is-referenced-by-count":37,"title":["In vivo efficacy of HDL-like nanolipid particles containing multivalent peptide mimetics of apolipoprotein A-I"],"prefix":"10.1016","volume":"55","author":[{"given":"Yannan","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey S.","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J.","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce E.","family":"Maryanoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda K.","family":"Curtiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke J.","family":"Leman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Reza","family":"Ghadiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1194\/jlr.M049262_bib1","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2174\/138161210791050988","article-title":"High-density lipoprotein-raising strategies: update 2010","volume":"16","author":"Spillmann","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1194\/jlr.M049262_bib2","doi-asserted-by":"crossref","first-page":"4134","DOI":"10.2174\/138161210794519228","article-title":"HDL therapy: two kinds of right?","volume":"16","author":"Murphy","year":"2010","journal-title":"Curr. Pharm. Des."},{"key":"10.1194\/jlr.M049262_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jacl.2010.08.018","article-title":"Emerging high-density lipoprotein infusion therapies: fulfilling the promise of epidemiology?","volume":"4","author":"Tardif","year":"2010","journal-title":"J. Clin. Lipidol."},{"key":"10.1194\/jlr.M049262_bib4","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.atherosclerosis.2010.05.035","article-title":"Anti-inflammatory effects of apolipoprotein A-I in the rabbit","volume":"212","author":"Patel","year":"2010","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.M049262_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.atherosclerosis.2005.12.019","article-title":"Overexpression of human apoA-I transgene provides long-term atheroprotection in LDL receptor-deficient mice","volume":"189","author":"Valenta","year":"2006","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.M049262_bib6","doi-asserted-by":"crossref","first-page":"3047","DOI":"10.1161\/hc2501.092494","article-title":"High-dose recombinant apolipoprotein A-I Milano mobilizes tissue cholesterol and rapidly reduces plaque lipid and macrophage content in apolipoprotein E-deficient mice. Potential implications for acute plaque stabilization","volume":"103","author":"Shah","year":"2001","journal-title":"Circulation."},{"key":"10.1194\/jlr.M049262_bib7","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1161\/01.ATV.15.11.1882","article-title":"Intravenous injection of rabbit apolipoprotein A-I inhibits the progression of atherosclerosis in cholesterol-fed rabbits","volume":"15","author":"Miyazaki","year":"1995","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M049262_bib8","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/353265a0","article-title":"Inhibition of early atherogenesis in transgenic mice by human apolipoprotein A-I","volume":"353","author":"Rubin","year":"1991","journal-title":"Nature."},{"key":"10.1194\/jlr.M049262_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.atherosclerosis.2013.08.010","article-title":"Reversal of atherosclerosis with apolipoprotein A1: Back to basics","volume":"232","author":"Smits","year":"2014","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.M049262_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehu171","article-title":"Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial epub ahead of print.","author":"Tardif","year":"2014","journal-title":"Eur. Heart J."},{"key":"10.1194\/jlr.M049262_bib11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.3949\/ccjm.79a.11166","article-title":"Is niacin ineffective? Or did AIM-HIGH miss its target?","volume":"79","author":"Nicholls","year":"2012","journal-title":"Cleve. Clin. J. Med."},{"key":"10.1194\/jlr.M049262_bib12","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1038\/bjp.2008.248","article-title":"The failure of torcetrapib: what have we learned?","volume":"154","author":"Joy","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1194\/jlr.M049262_bib13","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1038\/nm.2937","article-title":"The not-so-simple HDL story: Is it time to revise the HDL cholesterol hypothesis?","volume":"18","author":"Rader","year":"2012","journal-title":"Nat. Med."},{"key":"10.1194\/jlr.M049262_bib14","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet."},{"key":"10.1194\/jlr.M049262_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/MOL.0b013e328355ca25","article-title":"HDL functionality","volume":"23","author":"Soran","year":"2012","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.M049262_bib16","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1038\/nm.2930","article-title":"A new era for quantifying HDL and cardiovascular risk?","volume":"18","author":"Heinecke","year":"2012","journal-title":"Nat. Med."},{"key":"10.1194\/jlr.M049262_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1002\/emmm.201200224","article-title":"Molecular mechanisms of vascular effects of high-density lipoprotein: alterations in cardiovascular disease","volume":"4","author":"Besler","year":"2012","journal-title":"EMBO Mol. Med."},{"key":"10.1194\/jlr.M049262_bib18","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1097\/MOL.0b013e328338472d","article-title":"High-density lipoprotein heterogeneity and function in reverse cholesterol transport","volume":"21","author":"Rothblat","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.M049262_bib19","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2011.05.013","article-title":"Biological activities of HDL subpopulations and their relevance to cardiovascular disease","volume":"17","author":"Camont","year":"2011","journal-title":"Trends Mol. Med."},{"key":"10.1194\/jlr.M049262_bib20","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/1476-511X-10-175","article-title":"Emerging therapeutic strategies to enhance HDL function","volume":"10","author":"Redondo","year":"2011","journal-title":"Lipids Health Dis."},{"key":"10.1194\/jlr.M049262_bib21","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0304-3940(91)90291-Z","article-title":"Protective effect of CCK-8 and ceruletide on glutamate-induced neuronal cell death in rat neuron cultures: possible involvement of CCK-B receptors","volume":"132","author":"Katsuura","year":"1991","journal-title":"Neurosci. Lett."},{"key":"10.1194\/jlr.M049262_bib22","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1007\/s11883-010-0097-4","article-title":"Biological properties of apolipoprotein A-I mimetic peptides","volume":"12","author":"Getz","year":"2010","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1194\/jlr.M049262_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pharmthera.2010.12.003","article-title":"Apolipoprotein mimetic peptides: mechanisms of action as anti-atherogenic agents","volume":"130","author":"Osei-Hwedieh","year":"2011","journal-title":"Pharmacol. Ther."},{"key":"10.1194\/jlr.M049262_bib24","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11883-009-0008-8","article-title":"Apolipoprotein A-I mimetic peptides","volume":"11","author":"Van Lenten","year":"2009","journal-title":"Curr. Atheroscler. Rep."},{"key":"10.1194\/jlr.M049262_bib25","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/MED.0b013e32835056d4","article-title":"Apolipoprotein A-I mimetics and high-density lipoprotein function","volume":"19","author":"Gordon","year":"2012","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1194\/jlr.M049262_bib26","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1097\/MOL.0b013e3283404507","article-title":"Apolipoprotein A-I mimetic peptides","volume":"21","author":"Hovingh","year":"2010","journal-title":"Curr. Opin. Lipidol."},{"key":"10.1194\/jlr.M049262_bib27","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.pharmthera.2012.03.004","article-title":"Novel HDL-based therapeutic agents","volume":"135","author":"Joy","year":"2012","journal-title":"Pharmacol. Ther."},{"key":"10.1194\/jlr.M049262_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1161\/CIRCRESAHA.110.216507","article-title":"Structure\/function relationships of apolipoprotein A-I mimetic peptides: implications for antiatherogenic activities of high-density lipoprotein","volume":"107","author":"D'Souza","year":"2010","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.M049262_bib29","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1194\/jlr.M900151-JLR200","article-title":"An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide","volume":"50","author":"Wool","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M049262_bib30","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1194\/jlr.M020438","article-title":"An apoA-I mimetic peptibody generates HDL-like particles and increases alpha-1 HDL subfraction in mice","volume":"53","author":"Lu","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M049262_bib31","doi-asserted-by":"crossref","first-page":"13414","DOI":"10.1021\/ja404714a","article-title":"Mimicry of high-density lipoprotein: functional peptide-lipid nanoparticles based on multivalent peptide constructs","volume":"135","author":"Zhao","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1194\/jlr.M049262_bib32","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1161\/01.RES.0000190634.60042.cb","article-title":"Effects of D-4F on vasodilation and vessel wall thickness in hypercholesterolemic LDL receptor-null and LDL receptor\/apolipoprotein A-I double-knockout mice on Western diet","volume":"97","author":"Ou","year":"2005","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.M049262_bib33","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1161\/01.RES.0000194558.86099.ba","article-title":"An apolipoprotein A-I mimetic works best in the presence of apolipoprotein A-I","volume":"97","author":"Navab","year":"2005","journal-title":"Circ. Res."},{"key":"10.1194\/jlr.M049262_bib34","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/hc0302.103711","article-title":"Oral administration of an apo A-I mimetic peptide synthesized from D-amino acids dramatically reduces atherosclerosis in mice independent of plasma cholesterol","volume":"105","author":"Navab","year":"2002","journal-title":"Circulation."},{"key":"10.1194\/jlr.M049262_bib35","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S0022-2275(20)31163-9","article-title":"A new synthetic class A amphipathic peptide analogue protects mice from diet-induced atherosclerosis","volume":"42","author":"Garber","year":"2001","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M049262_bib36","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.atherosclerosis.2012.10.064","article-title":"Two apolipoprotein E mimetic peptides with similar cholesterol reducing properties exhibit differential atheroprotective effects in LDL-R null mice","volume":"227","author":"Handattu","year":"2013","journal-title":"Atherosclerosis."},{"key":"10.1194\/jlr.M049262_bib37","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1161\/ATVBAHA.112.300282","article-title":"High-density lipoprotein and 4F peptide reduce systemic inflammation by modulating intestinal oxidized lipid metabolism: novel hypotheses and review of literature","volume":"32","author":"Navab","year":"2012","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M049262_bib38","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1194\/jlr.M013144","article-title":"Intestine may be a major site of action for the apoA-I mimetic peptide 4F whether administered subcutaneously or orally","volume":"52","author":"Navab","year":"2011","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M049262_bib39","doi-asserted-by":"crossref","first-page":"2302","DOI":"10.1194\/jlr.M800075-JLR200","article-title":"Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I","volume":"49","author":"Van Lenten","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M049262_bib40","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1172\/JCI25482","article-title":"Modulation of atherosclerosis in mice by Toll-like receptor 2","volume":"115","author":"Mullick","year":"2005","journal-title":"J. Clin. Invest."},{"key":"10.1194\/jlr.M049262_bib41","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/j.1365-2362.1970.tb00595.x","article-title":"Precipitation by neomycin compounds of fatty acid and cholesterol from mixed micellar solutions","volume":"1","author":"Thompson","year":"1970","journal-title":"Eur. J. Clin. Invest."},{"key":"10.1194\/jlr.M049262_bib42","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3109\/00365518209168072","article-title":"Effects of neomycin alone and in combination with cholestyramine on serum methyl sterols and conversion of acetate and mevalonate to cholesterol","volume":"42","author":"Miettinen","year":"1982","journal-title":"Scand. J. Clin. Lab. Invest."},{"key":"10.1194\/jlr.M049262_bib43","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3181\/00379727-102-25358","article-title":"Effect of an anion exchange resin on serum cholesterol in man","volume":"102","author":"Bergen","year":"1959","journal-title":"Proc. Soc. Exp. Biol. Med."},{"key":"10.1194\/jlr.M049262_bib44","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1001\/archinte.1972.03650040162015","article-title":"Treatment of hypercholesterolemia by interference with bile acid metabolism","volume":"130","author":"Grundy","year":"1972","journal-title":"Arch. Intern. Med."},{"key":"10.1194\/jlr.M049262_bib45","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0955-2863(03)00054-8","article-title":"Effect of EGCG on lipid absorption and plasma lipid levels in rats","volume":"14","author":"Raederstorff","year":"2003","journal-title":"J. Nutr. Biochem."},{"key":"10.1194\/jlr.M049262_bib46","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1021\/jf050447x","article-title":"Naturally derived micelles for rapid in vitro screening of potential cholesterol-lowering bioactives","volume":"53","author":"Kirana","year":"2005","journal-title":"J. Agric. Food Chem."},{"key":"10.1194\/jlr.M049262_bib47","doi-asserted-by":"crossref","first-page":"e27662","DOI":"10.1371\/journal.pone.0027662","article-title":"The intestinal flora is required to support antibody responses to systemic immunization in infant and germ free mice","volume":"6","author":"Lamous\u00e9-Smith","year":"2011","journal-title":"PLoS ONE."},{"key":"10.1194\/jlr.M049262_bib48","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1476-511X-12-67","article-title":"Effects of NS lactobacillus strains on lipid metabolism of rats fed a high-cholesterol diet","volume":"12","author":"Hu","year":"2013","journal-title":"Lipids Health Dis."},{"key":"10.1194\/jlr.M049262_bib49","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1472-765X.2008.02408.x","article-title":"Development of a real-time PCR method for Firmicutes and Bacteroidetes in feces and its application to quantify intestinal population of obese and lean pigs","volume":"47","author":"Guo","year":"2008","journal-title":"Lett. Appl. Microbiol."},{"key":"10.1194\/jlr.M049262_bib50","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/AC.67.1.2146561","article-title":"A critical reassessment of murine and rabbit models of atherosclerosis: focus on lesion progression and remodelling","volume":"67","author":"Van Craeyveld","year":"2012","journal-title":"Acta Cardiol."},{"key":"10.1194\/jlr.M049262_bib51","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1161\/ATVBAHA.107.142570","article-title":"Mouse models for atherosclerosis and pharmaceutical modifiers","volume":"27","author":"Zadelaar","year":"2007","journal-title":"Arterioscler. Thromb. Vasc. Biol."},{"key":"10.1194\/jlr.M049262_bib52","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1194\/jlr.M033555","article-title":"A novel approach to oral apoA-I mimetic therapy","volume":"54","author":"Chattopadhyay","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M049262_bib53","doi-asserted-by":"crossref","first-page":"3403","DOI":"10.1194\/jlr.M042051","article-title":"Transgenic 6F tomatoes act on the small intestine to prevent systemic inflammation and dyslipidemia caused by Western diet and intestinally derived lysophosphatidic acid","volume":"54","author":"Navab","year":"2013","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M049262_bib54","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1194\/jlr.P800003-JLR200","article-title":"Safety, pharmacokinetics, and pharmacodynamics of oral apoA-I mimetic peptide D-4F in high-risk cardiovascular patients","volume":"49","author":"Bloedon","year":"2008","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M049262_bib55","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1194\/jlr.M003665","article-title":"A new HDL mimetic peptide that stimulates cellular cholesterol efflux with high efficiency greatly reduces atherosclerosis in mice","volume":"51","author":"Bielicki","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M049262_bib56","doi-asserted-by":"crossref","first-page":"3491","DOI":"10.1194\/jlr.M006916","article-title":"Oral administration of L-mR18L, a single domain cationic amphipathic helical peptide, inhibits lesion formation in ApoE null mice","volume":"51","author":"Handattu","year":"2010","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M049262_bib57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1161\/01.CIR.99.1.105","article-title":"Somatic gene transfer of human apoA-I inhibits atherosclerosis progression in mouse models","volume":"99","author":"Benoit","year":"1999","journal-title":"Circulation."},{"key":"10.1194\/jlr.M049262_bib58","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/bjp.2008.122","article-title":"Regression of aortic valve stenosis by ApoA-I mimetic peptide infusions in rabbits","volume":"154","author":"Busseuil","year":"2008","journal-title":"Br. J. Pharmacol."},{"key":"10.1194\/jlr.M049262_bib59","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1194\/jlr.M023523","article-title":"D-4F-mediated reduction in metabolites of arachidonic and linoleic acids in the small intestine is associated with decreased inflammation in low-density lipoprotein receptor-null mice","volume":"53","author":"Navab","year":"2012","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M049262_bib60","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1194\/jlr.M800539-JLR200","article-title":"A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids","volume":"50","author":"Navab","year":"2009","journal-title":"J. Lipid Res."},{"key":"10.1194\/jlr.M049262_bib61","doi-asserted-by":"crossref","first-page":"19997","DOI":"10.1073\/pnas.1009010107","article-title":"Apolipoprotein A-I (apoA-I) and apoA-I mimetic peptides inhibit tumor development in a mouse model of ovarian cancer","volume":"107","author":"Su","year":"2010","journal-title":"Proc. Natl. Acad. Sci. USA."},{"key":"10.1194\/jlr.M049262_bib62","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/01.CIR.0000089375.60050.35","article-title":"Oral synthetic phospholipid (DMPC) raises high-density lipoprotein cholesterol levels, improves high-density lipoprotein function, and markedly reduces atherosclerosis in apolipoprotein E-null mice","volume":"108","author":"Navab","year":"2003","journal-title":"Circulation."},{"key":"10.1194\/jlr.M049262_bib63","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1258\/ebm.2010.009320","article-title":"Synthetic dimyristoylphosphatidylcholine liposomes assimilating into high-density lipoprotein promote regression of atherosclerotic lesions in cholesterol-fed rabbits","volume":"235","author":"Cho","year":"2010","journal-title":"Exp. Biol. Med. (Maywood)."},{"key":"10.1194\/jlr.M049262_bib64","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1038\/nature12820","article-title":"Diet rapidly and reproducibly alters the human gut microbiome","volume":"505","author":"David","year":"2014","journal-title":"Nature."},{"key":"10.1194\/jlr.M049262_bib65","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1136\/gutjnl-2011-301012","article-title":"Metabolic adaptation to a high-fat diet is associated with a change in the gut microbiota","volume":"61","author":"Serino","year":"2012","journal-title":"Gut."},{"key":"10.1194\/jlr.M049262_bib66","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/ismej.2013.155","article-title":"High-fat diet alters gut microbiota physiology in mice","volume":"8","author":"Daniel","year":"2014","journal-title":"ISME J."},{"key":"10.1194\/jlr.M049262_bib67","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.chom.2008.02.015","article-title":"Diet-induced obesity is linked to marked but reversible alterations in the mouse distal gut microbiome","volume":"3","author":"Turnbaugh","year":"2008","journal-title":"Cell Host Microbe."},{"key":"10.1194\/jlr.M049262_bib68","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1053\/j.gastro.2009.08.042","article-title":"High-fat diet determines the composition of the murine gut microbiome independently of obesity","volume":"137","author":"Hildebrandt","year":"2009","journal-title":"Gastroenterology."},{"key":"10.1194\/jlr.M049262_bib69","doi-asserted-by":"crossref","first-page":"ra14","DOI":"10.1126\/scitranslmed.3000322","article-title":"The effect of diet on the human gut microbiome: a metagenomic analysis in humanized gnotobiotic mice","volume":"1","author":"Turnbaugh","year":"2009","journal-title":"Sci. Transl. Med."},{"key":"10.1194\/jlr.M049262_bib70","doi-asserted-by":"crossref","first-page":"78ps12","DOI":"10.1126\/scitranslmed.3001626","article-title":"Community health care: therapeutic opportunities in the human microbiome","volume":"3","author":"Sonnenburg","year":"2011","journal-title":"Sci. Transl. Med."},{"key":"10.1194\/jlr.M049262_bib71","doi-asserted-by":"crossref","first-page":"rv5","DOI":"10.1126\/scitranslmed.3004183","article-title":"Microbiota-targeted therapies: an ecological perspective","volume":"4","author":"Lemon","year":"2012","journal-title":"Sci. Transl. Med."},{"key":"10.1194\/jlr.M049262_bib72","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature09922","article-title":"Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease","volume":"472","author":"Wang","year":"2011","journal-title":"Nature."},{"key":"10.1194\/jlr.M049262_bib73","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N. Engl. J. Med."},{"key":"10.1194\/jlr.M049262_bib74","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev.physiol.69.031905.160725","article-title":"Regulation of intestinal cholesterol absorption","volume":"69","author":"Wang","year":"2007","journal-title":"Annu. Rev. Physiol."}],"container-title":["Journal of Lipid Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520350094?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022227520350094?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1194\/jlr.M049262","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,11,20]],"date-time":"2021-11-20T18:42:47Z","timestamp":1637433767000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022227520350094"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":74,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0022227520350094"],"URL":"https:\/\/doi.org\/10.1194\/jlr.m049262","relation":{},"ISSN":["0022-2275"],"issn-type":[{"value":"0022-2275","type":"print"}],"subject":[],"published":{"date-parts":[[2014,10]]}}}